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Stromal cells differentially regulate neutrophil and lymphocyte
recruitment through the endothelium
Introduction
Extravasation of circulating leucocytes is required for
immune surveillance and the inflammatory response to
tissue injury and infection. After exposure to inflamma-
tory cytokines, endothelial cells (EC) present selectins and
vascular cell adhesion molecule-1 (VCAM-1), which can
capture flowing neutrophils and lymphocytes (reviewed in
ref. 1). Endothelial surface-presented chemokines may
then cause activation of leucocyte integrins (e.g. integrins
a4b1 or b2), which support stable attachment and onward
migration. For flowing neutrophils, CXC-chemokines
induce stable attachment to EC which have been stimu-
lated with tumour necrosis factor-a (TNF-a),2 but we
have recently found that a subsequent signal from prosta-
glandin D2 is also required for efficient transendothelial
migration.3 Flow studies in vitro reveal that lymphocytes
can also migrate rapidly through activated EC.4–7 In the
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Summary
Stromal fibroblasts modify the initial recruitment of leucocytes by endo-
thelial cells (EC), but their effects on subsequent transendothelial migra-
tion remain unclear. Here, EC and dermal or synovial fibroblasts were
cultured on opposite surfaces of 3-lm pore filters and incorporated in
static or flow-based migration assays. Fibroblasts had little effect on
tumour necrosis factor-a-induced transendothelial migration of neutroph-
ils, but tended to increase the efficiency of migration away from the endo-
thelium. Surprisingly, similar close contact between EC and fibroblasts
strongly reduced lymphocyte migration in static assays, and nearly abol-
ished stable lymphocyte adhesion from flow. Fibroblasts did not alter
endothelial surface expression of adhesion molecules or messenger RNA
for chemokines. Inhibition of attachment did not occur when EC-fibro-
blast contact was restricted by using 04-lm pore filters, but under these
conditions pre-treatment with heparinase partially inhibited adhesion. In
the 3-lm pore co-cultures, inhibition of metalloproteinase activity par-
tially recovered lymphocyte adhesion, but addition of CXCL12 (SDF-1a)
to the endothelial surface did not. Hence, the ability of EC to present acti-
vating chemokines for lymphocytes may have been enzymatically inhib-
ited by direct contact with fibroblasts. To avoid contact, we cultured EC
and fibroblasts on separate 3-lm pore filters one above the other. Here,
fibroblasts promoted the transendothelial migration of lymphocytes.
Fibroblasts generate CXCL12, but blockade of CXCL12 receptor had no
effect on lymphocyte migration. While stromal cells can provide signal(s)
promoting leucocyte migration away from the sub-endothelial space,
direct cell contact (which might occur in damaged tissue) may cause dis-
ruption of chemokine signalling, specifically inhibiting lymphocyte rather
than neutrophil recruitment.
Keywords: endothelial cells; fibroblasts; lymphocytes; migration; neutrophils
Abbreviations: EC, endothelial cells; IFN-c, interferon-c; PBL, peripheral blood lymphocytes; TNF-a, tumour necrosis factor-a.
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case of treatment with TNF-a plus interferon-c (IFN-c),
chemokines acting through CXCR3 were shown to stabi-
lize lymphocyte attachment, but the signals inducing
transmigration were not defined.5,8 Exogenous CXCL12
(SDF1-a) added to the surface of EC promoted transmi-
gration,9 but this agent is not produced by the EC them-
selves. Recently, we reported the continuous migration of
lymphocytes back and forth across cytokine-treated endo-
thelial monolayers in a ‘frustrated’ manner.7 In addition,
lymphocytes showed little penetration of substrates (such
as collagen gel) underneath cultured EC even after
hours.7,10,11 On the other hand, neutrophils quickly infil-
trated collagen gels underneath cytokine-treated endothe-
lium.7 We proposed that lymphocytes might be actively
retained by EC until a separate stromal signal induces
migration into the underlying tissue.7
There is increasing evidence that interactions between
various stromal cells and EC influence the recruitment of
leucocytes.8,12–17 However, the role of pericytes as regula-
tors of the endothelial-mediated leucocyte recruitment
remains ambiguous. We showed that co-culturing EC
with secretory smooth muscle cells augmented cytokine-
induced capture of flowing leucocytes.14 Furthermore,
hepatocytes promoted lymphocyte adhesion to hepatic
sinusoidal EC in response to lymphotoxin.15 More
recently we reported that rheumatoid synovial fibroblasts
directly induced endothelial capture of flowing neutroph-
ils and lymphocytes.8,16,17 In contrast, dermal fibroblasts
cultured with EC reduced lymphocyte adhesion induced
by TNF-a + IFN-c.8 None of these studies addressed the
ability of the recruited leucocytes to migrate through the
EC and stroma, because the co-cultured cells were on
either side of 04-lm pore filters, which did not allow
passage of cells. Others have shown that culturing endo-
thelial and epithelial cells on opposite sides of 3-lm pore
filters marginally enhanced neutrophil chemotaxis to
interleukin-8 (IL-8).13 On the other hand, renal tubular
epithelial cells inhibited migration of neutrophils through
TNF-a treated EC.18 Dermal fibroblasts from scleroderma
patients promoted the migration of a T-cell line through
an immortalized EC line coated on an 8-lm pore filter,12
when the fibroblasts were cultured on the plate under-
neath.
Here we examined whether fibroblasts isolated from
the skin or the synovium of patients with rheumatoid
arthritis could provide signals to recruited leucocytes, spe-
cifically releasing lymphocytes from the endothelium and/
or improving their migration efficiency. Initially, the cells
were cultured on opposite surfaces of 3-lm pore filters to
enable studies of migration through the complete con-
struct. Because we found unexpected inhibition of recruit-
ment of lymphocytes when fibroblasts and EC were
brought into such close contact, we also carried out stud-
ies using smaller pore filters, and using EC and fibroblasts
on closely juxtaposed but separate filters. These studies
revealed that fibroblasts could have different effects on
neutrophil or lymphocyte recruitment, depending on the
degree of the contact with the EC.
Methods
Isolation of human leucocytes, fibroblasts and endothelial
cells
Venous blood from healthy individuals was collected in
EDTA tubes (Sarstedt, Leicester, UK). Neutrophils were
isolated by centrifugation using a two-step density gradi-
ent as described.19 Peripheral blood lymphocytes (PBL)
were isolated using Histopaque 1077 followed by panning
on culture plastic to remove contaminating mono-
cytes.7,8,20 Isolated cells were washed, counted and
adjusted to the desired concentration in phosphate-buf-
fered saline containing Ca2+, Mg2+ and 5 mM glucose or
Medium 199 (Gibco Invitrogen Compounds, Paisley,
UK), both supplemented with 015% bovine serum albu-
min (Sigma-Aldrich, Poole, UK) (PBSA or M199BSA
respectively). The PBSA was used for short perfusions in
flow-based assays, while M199BSA was used for longer
cultures of leucocytes with EC. In some experiments, lym-
phocytes were treated for 15 min with 1 mg/ml of the
CXCR4 inhibitor, AMD3100 (AnorMED Inc., Langley,
BC, Canada). We have previously demonstrated that this
treatment inhibits lymphocyte recruitment from flow to
EC co-cultured with synovial fibroblasts.8
Tissue samples from synovium and overlying skin were
obtained from the same patients with rheumatoid arthritis
and fibroblasts were isolated as previously described.21 Cells
were cultured in RPMI-1640 (Gibco Invitrogen Com-
pounds) supplemented with 10% heat inactivated fetal calf
serum, minimum essential medium–non-essential amino
acids, 1 mM sodium pyruvate, 2 mM L-glutamine, 100 U/ml
penicillin and 100 lg/ml streptomycin (all from Sigma)
and used between passages 5 and 9.8
Human umbilical vein endothelial cells (HUVEC)
were isolated from umbilical cords using collagenase as
previously described22 and cultured in M199 supple-
mented with 20% fetal calf serum, 1 ng/ml epidermal
growth factor, 35 lg/ml gentamycin, 1 lg/ml hydrocorti-
sone (all from Sigma) and 25 lg/ml amphotericin B
(Gibco Invitrogen Compounds).8 All human tissue was
obtained with informed consent and with approval
from the South Birmingham Local Research Ethics
Committee.
Culture of endothelial cells and fibroblasts on Transwell
filters
Fibroblasts and EC were dissociated using trypsin/EDTA
(Sigma) and co-cultured on the opposite sides of 24-well
or six-well, low-density, 30 lm or 04 lm pore Transwell
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filter inserts (BD Pharmingen, Cowley, UK) as described.8
Fibroblasts were seeded onto inverted filters at densities
based on previous reports8,16 and cultured for 24 hr. HU-
VEC were then seeded on the inner surface of filters at a
concentration that yielded confluent monolayers within
24 hr. For comparison, parallel cultures of HUVEC were
seeded inside filters without fibroblasts. The cells were
cultured in fibroblast medium for 24 hr or 4 days, after
which 100 U/ml TNF-a (Sigma) was added alone or in
combination with 10 ng/ml IFN-c (Peprotech Inc., Lon-
don, UK) for 4 or 24 hr. In some experiments, a neutral-
izing antibody against IL-6 (clone 6708, 5 lg/ml; R&D
Systems, Abingdon, Oxfordshire, UK) was added when
co-culture was established and was present during cyto-
kine treatment. We have previously demonstrated that
this treatment inhibits the ability of fibroblasts to modu-
late EC recruitment of leucocytes from flow.8,16 Alterna-
tively, cytokine-treated endothelial mono- and co-cultures
were treated with 100 ng/ml CXCL12 (SDF-1; Peprotech)
for 30 min before assay. In another series, EC were cul-
tured alone for 4 days to establish a stable monolayer
before co-culture with fibroblasts for 24 hr.
The following enzymes or enzyme inhibitors were
added to co-cultures when desired, and were present dur-
ing the cytokine treatment: 10 lM galardin [a broad-spec-
trum inhibitor of matrix metalloproteinase (MMP) and
some ADAM (a disintegrin and metalloproteinase) family
members; BioMed International, Exeter, UK]; 10 mU/ml
heparinase I (bacterial homologue to human heparin-
ase23) (Oxford Glycosciences, Abingdon, UK); 30 U/ml
hyaluronidase (broad spectrum enzyme which cleaves
hyaluronan and chrondroitin sulphate); 100 lg/ml a1-an-
titrypsin (inhibits trypsin, chymotrypsin, pancreatic and
granulocytic elastase and acrosin); 50 lg/ml aprotinin
(broad-spectrum serine protease inhibitor) (all from
Sigma).
For studies to investigate soluble mediators, conditioned
medium was collected from unstimulated fibroblasts or
co-cultures. Subsequently, an endothelial monolayer was
cultured in this conditioned medium along with TNF-
a + IFN-c for 24 hr. Alternatively, conditioned medium
was collected from endothelial mono- or co-cultures fol-
lowing 24 hr of stimulation with TNF-a + IFN-c, and
transferred to a second endothelial monolayer for 24 hr.
Migration of leucocytes through Transwell filters – static
assay
Leucocyte migration was assessed using 24-well format
Transwell filters as previously described.7,24 Co-cultures
were washed to remove residual cytokines, fresh M199BSA
was placed in the lower chamber and purified leucocytes
(200 ll at 2 · 106cells/ml) were added to the upper cham-
ber. The cells were allowed to settle, adhere and migrate at
37 in a CO2 incubator for the desired period, typically
2 hr for neutrophils and 24 hr for PBL. Migration was
stopped at the chosen time by transferring the filter into a
fresh well, leaving the transmigrated cells in the original
lower chamber. The leucocytes suspended in the upper
chamber were removed, and pooled with cells obtained
when the filter was washed twice. These cells were taken to
represent non-adherent cells.
For neutrophils, the non-adherent and transmigrated
cells were counted using a Coulter Multisizer II (Coulter
Electronics Ltd, Essex, UK). Adherent cells (representing
all cells that bound to the culture whether they transmi-
grated or not) were calculated by subtracting the non-
adherent population from the total number of cells added
to each well. From the known number of added neutroph-
ils, the percentages that adhered or transmigrated were cal-
culated. For lymphocytes, cells were counted and their
surface phenotypes were analysed by flow cytometry.
Freshly isolated, non-adherent or transmigrated cells were
labelled with phycoerythrin-conjugated anti-CD4, fluores-
cein isothiocyanate-conjugated anti-CD8 (Becton Dickin-
son, Oxford, UK) or Cy5-conjugated anti-CD45RA
(Serotec, Oxford, UK) for 30 min on ice. Fixed volume
counts for positively labelled cells were made using a Coul-
ter XL flow cytometer and analysed using WINMDI soft-
ware. In this way, we calculated the percentages of CD4+,
CD8+ and memory T-cells that adhered and transmigrated.
Again, adherent cells were calculated by subtracting the
non-adherent counts from the total number of cells added.
In a variant on this assay, EC or fibroblasts were cul-
tured on the inner surface of 24- or 12-well 3-lm pore
Transwell filter inserts respectively. After 24 hr, the 24-
well inserts were fitted into the 12-well inserts and cells
were cultured together for 24 hr. This arrangement
brought the EC within about 250 lm of the fibroblasts
but did not allow contact. Co-cultures were treated with
cytokines as above. The PBL were added and allowed to
adhere for 10 min after which non-adherent cells were
removed and analysed by flow cytometry as above. After
24 hr, migrated cells suspended in the medium between
the two filters or in the lower chamber were collected. Fil-
ters were treated with Accutase (Gibco) to dissociated
migrated cells associated with the endothelial or fibroblast
monolayers, and washed twice. Cells from each compart-
ment were pooled with their respective washes and analy-
sed by flow cytometry as above. Migration was quantified
as the sum of the lymphocytes located in the compart-
ments beneath the endothelial monolayer; i.e. in medium
between the two filters, attached to the fibroblasts or in
the lowest chamber.
Leucocyte recruitment from flow and subsequent
migration through co-cultures
Filters were cut from the six-well format Transwell hold-
ers, placed on a 75 · 25 mm coverslip and incorporated
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into a parallel-plate flow chamber; the chamber was
attached to a perfusion system and mounted on the stage
of a phase-contrast videomicroscope, all at 37, as
described previously.8,25 At one end, the chamber was
connected to a Harvard withdrawal syringe pump, which
delivered flow at a rate equivalent to a wall shear stress of
01 Pa. At the other end, it was connected to an elec-
tronic valve (Lee Products, Gerrards Cross, UK) which
selected flow from reservoirs containing purified leuco-
cytes or cell-free PBSA. A 4-min bolus of leucocytes was
perfused over the EC followed by cell-free wash buffer.
Video recordings were made of five microscope fields
along the centreline of the flow channel after 2 and
11 min of washout. By adjusting the focus, recordings
were made of endothelial surface and then of the under-
side of the filter, the fibroblast layer and the coverslip sur-
face. Between these times, a single recording was made of
the endothelial surface to allow lymphocyte migration
velocity to be analysed.
The video recordings were digitized and analysed off-
line using IMAGE-PRO PLUS software (Media Cybernetics
UK, Marlow, UK). Leucocytes bound to the endothelium
were counted, and each was classified as either: (i) rolling
adherent (spherical cells moving over the surface much
slower than free-flowing cells); (ii) stationary or firmly
adherent (typically with distorted shape and actually
migrating slowly on the surface); (iii) transmigrated
under the endothelial monolayer (phase dark and spread).
Cells migrated into the layers below the filter were also
counted. Transmigrated cells were subdivided into cells
located above or beneath the filter. The total number of
adherent leucocytes (i.e. all behaviours) was averaged per
field and expressed /mm2/106 cells perfused.26
The migration velocities of phase-dark neutrophils
underneath the endothelium were measured by digitizing
a sequence of images 10 seconds apart for 5 min. Individ-
ual cells were outlined and the position of their centroid
was determined each minute. Migration velocity (lm/
min) was the average distance moved by the centroid per
minute.
Gene expression by EC
Trypsin/EDTA was used to detach HUVEC from the
inside of filters, and messenger RNA (mRNA) was iso-
lated from the cells using the RNeasy Mini Kit (Qiagen,
Crawley, UK). The mRNA levels of CXCL9, -10 and -11
chemokines were analysed by reverse transcription–poly-
merase chain reaction (RT–PCR), followed by densitom-
etry of product bands run on agarose gels containing
ethidium bromide, as described.8 The mRNA for E-selec-
tin, VCAM-1 and b-actin was analysed by quantitative
real-time PCR using a Quanti-Tect probe RT-PCR kit
as described previously.8 The VCAM-1 and E-selectin 6-
carboxy-fluorescein (FAM)-labelled primers and b-actin
VIC-labelled primers were bought as Assay on Demand
kits from Applied Biosystems (Warrington, UK). Samples
were amplified using the 7900HT Real-Time PCR
machine and analysed using the software package SDS
2.2 (Applied Biosystems). Data were expressed as relative
expression units to b-actin.
Flow cytometry of endothelial surface receptors
Filters were incubated with non-conjugated antibodies
against E-selectin (1.2B6) or VCAM-1 (1.4C3; both Dako,
Ely, UK) or with mouse immunoglobulin G1 as negative
control for 30 min at 4, washed and incubated with goat
anti-mouse fluorescein isothiocyanate-conjugated second-
ary antibody (Dako) for 30 min at 4 as previously
described.8 All samples were washed and incubated with
enzyme-free cell dissociation buffer (Gibco) for 30 min.
The EC were retrieved, washed and analysed using a
Coulter XL flow cytometer. Data were expressed as med-
ian fluorescent intensity.
Statistical analysis
Variation between multiple treatments was evaluated
using analysis of variance (ANOVA), followed by Dunnett
test for comparison with control or Bonferroni multiple
comparison test as appropriate. P < 005 was considered
as statistically significant.
Results
Migration of neutrophils through co-cultures of EC
and fibroblasts
We first investigated whether fibroblasts modified neutro-
phil migration through endothelium when the two cell
types were cultured on opposite sides of 3-lm pore fil-
ters, with or without TNF-a treatment. In a static assay,
neutrophils adhered to and migrated through EC more
efficiently after TNF-a treatment (Fig. 1a,b), but co-cul-
ture with fibroblasts had no significant effect on adhesion
or migration, with or without endothelial stimulation
(Fig. 1a,b). Next, we extended the duration of co-culture
to 4 days and re-examined effects on migration after
treatment with TNF-a. Under these conditions, migration
tended to be increased when EC were cultured with fibro-
blasts, but this effect was of borderline statistical signifi-
cance (Fig. 1c; P = 006 by ANOVA). Hence, under static
conditions, the presence of fibroblasts has only slight
effects on neutrophil migration.
Subsequently, we directly observed the effects of
fibroblasts on neutrophil recruitment from flow and sub-
sequent migration using a novel filter-based assay.8,25
Synovial fibroblasts induced the capture of flowing neu-
trophils to otherwise unstimulated EC (353 ± 102 adher-
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ent cells/mm2/106 perfused compared with 31 ± 82
adherent cells/mm2/106 perfused for unstimulated EC
mono-cultures; mean ± SEM; n = 3), in agreement with
our previous reports.16,17 The neutrophils were stationary
adherent, but rarely underwent transendothelial migration
(< 1% of adherent cells transmigrated, data not shown).
After TNF-a treatment, co-cultures and EC cultured alone
efficiently bound similar numbers of flowing neutrophils
(Fig. 2a). Under these conditions, most captured neu-
trophils were rapidly activated and became stationary
adherent, with  40–50% migrating through the endothe-
lial monolayer after 11 min of washout. The overall pro-
portion of adherent cells transmigrating did not vary
significantly between monocultures or co-cultures
(Fig. 2b). However, when migrated cells were divided into
those above or below the filter, the presence of fibroblasts
induced a greater proportion of migrated neutrophils to
pass through the filter (Fig. 2c).
We also noted that the velocity of cells migrating
immediately below the endothelial monolayer tended to
be slower in the presence of fibroblasts (68 ± 37 lm/
min with dermal or 63 ± 21 lm/min with synovial
co-cultures) compared with EC alone (90 ± 12 lm/min;
mean ± SEM for three experiments), although this did
not reach statistical significance. Overall, fibroblasts had
relatively little effect on the migration of neutrophils
across the EC, but tended to alter behaviour under the
endothelium and promote onward migration.
Migration of lymphocytes through co-cultures of EC
and fibroblasts
We examined the ability of fibroblasts to modify the adhe-
sion and migration of lymphocytes through EC with or
without TNF-a + IFN-c. Under static conditions, in the
absence of cytokine treatment, PBL and CD4+ or CD8+ T-
cell subsets (enumerated separately by flow cytometry)
tended to be bound less efficiently to EC co-cultured with
fibroblasts compared with EC cultured alone (Fig. 3a).
Few lymphocytes migrated through the unstimulated cul-
tures, but again, fewer migrated through co-cultures than
endothelial monocultures (Fig. 3b). Adhesion and trans-
migration were increased and less variable after cytokine
treatment. Under these conditions, dermal fibroblasts sig-
nificantly inhibited adhesion compared with EC cultured
alone, and co-culture with either type of fibroblast mark-
edly reduced transmigration (Fig. 3). Similar suppression
of migration by fibroblasts was observed when TNF-a
alone was used as the stimulus (data not shown).
The above effects were evident for both the CD4+ and
CD8+ T-cell subsets (Fig. 3). In general, there was enrich-
ment of memory CD4+ T cells in the migrated popula-
tion, as has been reported previously.7,10,11,27 For
example, despite the overall reduction of transmigration,
CD45RA) (memory) cells represented 83 ± 7% or
91 ± 4% of CD4+ T cells migrated through dermal or
synovial co-cultures respectively, compared with 62 ± 2%
in the original PBL population (mean ± SEM; n = 3 in
each case; P < 001 by Dunnett test). Hence, there was an
overall inhibition of the migratory process, rather than
the loss of a specific lymphocyte sub-population.
Recruitment of flowing lymphocytes by co-cultures
The inhibition of lymphocyte migration might arise from
reduction in migration through the endothelial monolayer
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Figure 1. Neutrophil adhesion and transmigration through endothe-
lial cells (EC) cultured with fibroblasts under static conditions.
Fibroblasts were cultured with EC for 24 hr and left untreated or
stimulated with 100 U/ml tumour necrosis factor-a (TNF) for the
last 4 hr. (a) Adhesion and (b) transmigration were analysed 2 hr
after the addition of neutrophils and expressed as percentages of
neutrophils added. Analysis of variance (anova) showed a significant
effect of TNF stimulation on neutrophil adhesion and transmigration
(P < 005), but no effect of fibroblasts. (c) Neutrophil migration
through co-cultures established for 4 days before assay. anova
showed an effect of fibroblasts with borderline significance, P = 006.
Data are mean ± SEM from three or four independent experiments.
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and/or through the filter and fibroblast layers, as well as
some contribution from impaired adhesion. To evaluate
these possibilities, we directly observed recruitment from
flow. As expected, few flowing PBL bound to unstimu-
lated EC, and cytokine-treatment greatly increased adhe-
sion to monocultures (Fig. 4a). Surprisingly, co-culture
with either dermal or synovial fibroblasts ablated lympho-
cyte adhesion to EC whether treated with TNF-a + IFN-c
or not (Fig. 4a). Similar loss of binding was observed for
co-cultures treated with TNF-a alone (data not shown).
We did not detect such dramatic loss of attachment when
essentially identical co-cultures were formed on opposite
sides of 04-lm pore filters,8 suggesting that cell–cell con-
tact may have been a critical determinant of the behav-
iour of the endothelial monolayer. Direct microscopic
observations did not reveal disruption of the endothelial
monolayers in co-cultures, whose appearance was identi-
cal to those in co-cultures that had supported efficient
neutrophil adhesion and migration. Observations of EC
or fibroblast mono-cultures did indicate that a few cells
of either type could cross the 3-lm pore filters in 24 hr.
To test whether prior stabilization of the endothelial
monolayer might alter the effect of fibroblasts, EC were
cultured on the 3-lm pore filters for 4 days before seed-
ing with fibroblasts. However, the recruitment of flowing
PBL was still dramatically reduced by co-culture with der-
mal or synovial fibroblasts (Fig. 4b).
Mechanism of inhibition of lymphocyte
recruitment – role of soluble mediators
We tested whether soluble mediators released by fibro-
blasts alone or in co-culture could inhibit lymphocyte
recruitment from flow. Conditioned medium from
unstimulated fibroblasts or from co-cultures with EC was
transferred to a separate endothelial monolayer, and
TNF-a + IFN-c was added for 24 hr. The conditioned
media did not reduce the adhesion of flowing lympho-
cytes compared with standard culture medium (Fig. 5a).
Hence, agents released by unstimulated fibroblasts or
co-cultures did not inhibit the subsequent response of EC
to the cytokines. Alternatively, conditioned medium from
cytokine-treated EC cultured alone or with fibroblasts was
transferred to a separate endothelial monolayer for 24 hr.
Once again, lymphocyte adhesion was similar with these
media to that obtained with fresh medium with cytokines
added (Fig. 5b). The conditioned medium from cytokine-
treated cultures was itself fully stimulatory. It seems,
therefore, that suppression of lymphocyte adhesion to
co-cultures did not arise from freely diffusing, released
soluble mediator(s).
Mechanism of inhibition of lymphocyte recruitment –
expression of adhesion receptors and chemokines by
EC
We previously reported that adhesion of flowing lympho-
cytes to EC that had been treated with TNF-a + IFN-c was
mainly supported through a4b1-integrins binding to
VCAM-1 on the EC, with a contribution from E-selectin;
stabilization of this attachment required activation of lym-
phocytes through CXCR3 binding its ligands (CXCL9,
CXCL10 and/or CXCL11).8 Using qPCR, we found that
co-culture had no significant effect on mRNA levels for E-
selectin, and tended to increase mRNA for VCAM-1 for EC
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Figure 2. Adhesion and behaviour of flowing neutrophils on cyto-
kine-treated co-cultures. Endothelial cells cultured alone or with
fibroblasts for 24 hr were subsequently stimulated with tumour
necrosis factor-a (TNF) for 4 hr before perfusion of a 4-min bolus
of neutrophils. (a) Number of neutrophils adherent to co-cultures
2 min after washout. (b) Behaviour of adherent neutrophils at
11 min after washout. (c) Location of migrated neutrophils above or
below the filter at 11 min expressed as a percentage of total transmi-
gration. In (c), analysis of variance shows a significant effect of cul-
ture conditions on the percentage of migrated neutrophils found
above or below the filter, P < 001. The percentage of migrated
neutrophils below the filter tended to be higher for co-cultures with
dermal fibroblasts than for monocultures; P = 0065 by paired t-test.
Data are mean ± SEM from three independent experiments.
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treated with TNF-a + IFN-c (Fig. 6a,b). As judged by flow
cytometry, surface expression of E-selectin and VCAM-1
on the EC was not significantly different for cytokine-trea-
ted EC cultured alone or with fibroblasts (Fig. 6c,d). The
RT-PCR for the CXCR3 ligands CXCL9, CXCL10 and
CXCL11 showed their up-regulation in EC by the cyto-
kines, but no difference in levels between EC cultured alone
or with fibroblasts (data not shown). Hence, the functional
loss observed in co-cultures could not be explained by
changes in expression of endothelial adhesion receptors
and chemokines identified as active in this model.
Mechanism of inhibition of lymphocyte recruitment –
endothelial surface modification
We considered the hypothesis that the effects of close
contact with the fibroblasts arose from inhibition of the
ability of the EC to present the chemokines necessary to
stabilize adhesion and promote subsequent migration. We
tried to replace ‘lost’ chemokines by incubating cytokine-
treated EC with CXCL12 immediately before perfusion of
lymphocytes. The CXCL12 enhanced adhesion to the EC
cultured alone, but was unable to recover any of the
(a) (b)
(c) (d)
Unstimulated
Adhesion
TNF + IFN
Adhesion
PBL
CD4+
CD8+
Migration
M
ig
ra
tio
n 
(%
)
Migration
Ad
he
sio
n 
(%
)
100
80
15
10
5
0
M
ig
ra
tio
n 
(%
)
40
30
20
10
0
60
40
20
None Dermal Synovial
None Dermal Synovial
Fibroblast in co-culture Fibroblast in co-culture
None Dermal Synovial
None Dermal
**
**
*
** ** **
** *
*
Synovial
0
Ad
he
sio
n 
(%
)
100
80
60
40
20
0
Figure 3. Effect of fibroblasts on the adhesion and migration of T-cell subsets under static conditions. Endothelial cells cultured alone or with
fibroblasts for 24 hr and were subsequently left untreated (a, c) or stimulated with tumour necrosis factor-a plus interferon-c (TNF + IFN) (b,
d). Adhesion (a, b) and migration (c, d) were assessed at 24 hr and expressed as a percentage of cells added for peripheral blood lymphocytes
(PBL), CD4+ or CD8+ T cells. Data are mean ± SEM from three independent experiments. In (b), analysis of variance (anova) shows a signifi-
cant effect of fibroblasts on T-cell adhesion, P < 001. In (c) and (d), anova shows a significant effect of fibroblasts on migration, P < 005.
* = P < 005 and ** = P < 001 compared with None by Dunnett test.
(a) (b)500 600
400
200
0
Untreated
TNF + IFN
** **
**
**
350
Ad
he
re
nt
 P
BL
(m
m2
/1
06
 
pe
rfu
se
d)
Ad
he
re
nt
 P
BL
(m
m2
/1
06
 
pe
rfu
se
d)
200
40
30
20
10
0
None Dermal Synovial
Fibroblast in co-culture
None Dermal Synovial
Fibroblast in co-culture
Figure 4. Effect of fibroblasts on lymphocyte recruitment from flow. (a) Fibroblasts were cultured alone for 24 hr, and then with endothelial cells
(EC) for 24 hr; co-cultures were then left untreated or stimulated with tumour necrosis factor-a plus interferon-c (TNF + IFN) for 24 hr. (b) EC
were cultured alone for 4 days, then with fibroblasts for 24 hr, and then TNF + IFN were added for 24 hr. Data are mean ± SEM from four
independent experiments. In (a) and (b), analysis of variance showed a significant effect of fibroblasts on lymphocyte adhesion (P < 001).
** = P < 001 compared to Untreated or None by Dunnett test.
 2010 The Authors. Journal Compilation  2010 Blackwell Publishing Ltd, Immunology 7
Modulation of leucocyte migration by fibroblasts
lymphocyte adhesion to co-cultures (Fig. 7a). This sug-
gested an inability of the EC to bind exogenous CXCL12
in the co-culture system. In general, surface-bound
chemokines are presented by glycoaminoglycans (GAGs)
which, with the exception of hyaluronan, are associated
with a protein backbone. Endothelial cells mainly express
the GAG heparan sulphate, along with lower levels of hy-
aluronan, chrondroitin sulphate and dermatan sul-
phate.28–31 We therefore investigated whether proteolytic
enzymes presented by fibroblasts in close contact with EC
might be the cause of loss of lymphocyte binding. Prote-
ase inhibitors were added to co-cultures of EC and syno-
vial fibroblasts grown on the 30-lm pore filters.
Inhibiting MMP activity (with galardin) caused a partial
recovery in lymphocyte recruitment to the cytokine-trea-
ted co-cultures (Fig. 7b), whereas serine protease inhibi-
tors had no effect. This suggested that loss of MMP-
sensitive protein structure(s) on the endothelial surface
during co-culture contributed to the reduction in lym-
phocyte adhesion.
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Returning to the co-cultures on 04-lm pore filters, we
further tested the concept that loss of GAGs could cause
reduction in the otherwise efficient binding of lympho-
cytes. Lymphocytes efficiently adhered to cytokine-treated
EC cultured alone or with synovial fibroblasts on the
small-pore filters (Fig. 7c), in agreement with our recent
report.8 Indeed, this cytokine-induced adhesion was sig-
nificantly inhibited when the co-cultures were treated
with heparinase (Fig. 7c). Treatment with hyaluronidase
did not modify adhesion (data not shown).
Overall, the above findings suggest that impaired pre-
sentation of chemokines by GAGs, brought about through
proteolytic cleavage of support structures, resulted in loss
of binding of lymphocytes when fibroblasts were cultured
in close contact with EC. Separation of the cells by 04-
lm pore filters was sufficient to nullify this phenomenon,
which could not be reproduced by soluble mediators
released by the various cultures tested.
Migration of lymphocytes through EC cultured with
fibroblasts without contact
The question of whether dermal or synovial fibroblasts
affect lymphocyte migration in the absence of close con-
tact with EC, could not be answered using the above
models. We therefore developed a model in which EC on
24-well, 3-lm pore filters were inserted above fibroblasts
on 12-well inserts, leaving a small space between the cells.
Under these conditions, fibroblasts increased adhesion of
CD4+ or CD8+ T cells to the EC and markedly increased
the migration of T cells through EC, with or without
treatment with cytokines (Fig. 8c,d).
Fibroblasts are known to secrete CXCL12,32–34 and we
recently demonstrated a role for this chemokine in the
recruitment of flowing lymphocytes to EC cultured with
synovial fibroblast.8 We therefore considered whether
migration was increased by the presence of this chemoki-
ne in the sub-endothelial compartment in co-cultures.
However, inhibition of its receptor CXCR4 on lympho-
cytes did not inhibit the increase in migration induced by
co-culture of EC with fibroblasts (Fig. 9a,b). Furthermore
neutralization of IL-6 during co-culture had no effect on
the increase in T-cell migration induced by fibroblasts
(Fig. 9c,d). Consequently, fibroblasts could promote leu-
cocyte migration away from the endothelium, but the
mechanism(s) remain uncertain.
Discussion
Efficient migration of leucocytes into tissue may require
more than a single migratory or chemotactic signal. We
have found that TNF-a-treated endothelial cells alone
can sequentially present CXC-chemokines and lipid
mediators to induce immobilization and transendothelial
and onward migration of neutrophils.2,3 On the other
hand, although lymphocytes readily adhere to and
migrate through cytokine-treated EC, many migrate back
and forth across the monolayer and onward migration is
much less efficient.7 Here, we set out to investigate
whether fibroblasts could provide additional migratory
signals for leucocytes, and especially make lymphocyte
migration more effective. Previously we found that
through soluble mediators, dermal fibroblasts could
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down-modulate the adhesion of lymphocytes to cyto-
kine-treated EC while fibroblasts from inflamed synovi-
um could induce adhesion themselves.8 Unexpectedly,
we found that close contact between fibroblasts and EC
cultured on either side of 3-m pore filters ablated lym-
phocyte capture from flow, and in static systems signifi-
cantly inhibited their migration through endothelium. In
contrast, neutrophil adhesion and migration remained
fully effective in essentially identical co-cultures. Indeed,
fibroblasts tended to increase the migration of neutroph-
ils away from the sub-endothelial compartment. Inhibi-
tion of lymphocyte adhesion was not observed if the
cells were cultured on either side of smaller pore (04-
lm) filters. Moreover, if the EC and fibroblasts were
cultured on separate 3-lm pore filters close together,
fibroblasts promoted transendothelial and onward migra-
tion of lymphocytes through the supporting filter.
Hence, stromal cells can powerfully influence the ability
of vascular EC to recruit flowing leucocytes and direct
their onward migration, with effects dependent on their
proximity.
The suppressive effects arising from close contact with
fibroblasts could not be reproduced by transferable solu-
ble mediators generated by resting or stimulated mono-
cultures or co-cultures, and were similar for both dermal
and synovial fibroblasts. Suppression could not be attrib-
uted to gross disruption of the endothelial monolayer,
which appeared undisturbed and was able to support effi-
cient adhesion and migration of neutrophils. The leuco-
cyte specificity suggested that fibroblasts selectively
modified endothelial expression of lymphocyte adhesion
receptors and/or chemokine ligands. Previously we dem-
onstrated that cytokine-induced lymphocyte adhesion to
endothelium was mediated through VCAM-1 and E-selec-
tin.8 However, here, fibroblasts did not cause loss of
endothelial expression of these adhesion receptors at
mRNA or protein levels. In addition, we and others
showed the importance of CXCR3 ligands in the stabiliza-
tion of lymphocyte adhesion to endothelium in cytokine-
driven models.5,8,35 Here, we found that cytokine-induced
up-regulation of the CXCR3-ligands CXCL9, CXCL10
and CXCL11 was not reduced by co-culture with fibro-
blasts. Our earlier work with inflammatory synovial fibro-
blasts and EC cultured on opposite sides of 04-lm pore
filters, indicated that endothelial presentation of fibro-
blast-derived CXCL12 was required for stable lymphocyte
adhesion.8 In the present study, EC cultured in close
proximity with these same cells did not support adhesion
from flow. The foregoing suggested to us that, if close
contact with fibroblasts impaired the ability of EC to
present (rather than generate) chemokines, this could
explain the phenomena observed.
40
CD4 adhesion
CD4 migration CD8 migration
CD8 adhesion
Ad
he
sio
n
(%
 of
 ce
lls
 ad
de
d)
30
** **
**
**
**
**
**
**
** **
* *20
10
0
M
ig
ra
tio
n
(%
 of
 ce
lls
 ad
de
d)
30
20
10
0
M
ig
ra
tio
n
(%
 of
 ce
lls
 ad
de
d)
30
20
10
0
40
Ad
he
sio
n
(%
 of
 ce
lls
 ad
de
d)
30
20
10
0
Untreated
TNF + IFN
Untreated
TNF + IFN
None Dermal Synovial
Fibroblast in co-culture
None Dermal Synovial
Fibroblast in co-culture
None Dermal Synovial
Fibroblast in co-culture
None Dermal Synovial
Fibroblast in co-culture
(a) (b)
(c) (d)
Figure 8. Adhesion and migration of lymphocytes through co-cultures in a two-filter static model. Co-cultures were established by inserting an
endothelial-coated 24-well filter into a fibroblast-coated 12-well filter. Cells were cultured together for 24 hr and then with or without tumour
necrosis factor-a plus interferon-c (TNF + IFN) for a further 24 hr. T-cell adhesion (a, b) and migration (c, d) were assessed after 10 min and at
24 hr, respectively, using flow cytometry. Data were expressed as a percentage of cells added. In (a) and (c), analysis of variance (anova) shows
a significant effect of fibroblasts on CD4+ T-cell adhesion (P < 005) and migration (P < 001). In (d), anova shows a significant effect of fibro-
blasts on CD8+ T-cell migration (P < 0001). Data are the mean ± SEM from six to nine (untreated) and 12 (TNF + IFN) independent experi-
ments. * = P < 005 and ** = P < 001 compared with endothelial cells cultured alone (none) with matched cytokine treatment by Dunnett test.
10  2010 The Authors. Journal Compilation  2010 Blackwell Publishing Ltd, Immunology
H. M. McGettrick et al.
Chemokines can be measured in culture-conditioned
media,36–41 but in our experience it is difficult to detect
their surface expression on EC. Pre-loading endothelial
monolayers with exogenous chemokines has been a strat-
egy employed to examine their ability to induce lympho-
cyte migration.6,42,43 For example, incubation of
endothelial monolayers with CXCL12 was reported to
promote transendothelial migration of lymphocytes in the
presence of flow.6 Here, pre-treatment of EC mono-cul-
tures with CXCL12 did enhance the adhesion of flowing
lymphocytes, but did not increase lymphocyte adhesion
to EC, which had been cultured in close contact with
fibroblasts. This showed that we could not re-establish
recruitment simply by adding back or substituting a miss-
ing chemokine, and supported the concept of impaired
ability of the EC to present chemokines.
Surface-bound chemokines are mainly presented by
GAGs which are themselves attached to a protein back-
bone (i.e. proteoglycans; reviewed in refs 31,44,45). For this
reason, we considered whether cleavage of GAGs or of
their support structures by fibroblasts might explain loss
of lymphocyte adhesion. Although released soluble
enzymes could not have been responsible for the loss of
presentation (judging from the lack of effect of the vari-
ous culture supernatants), direct contact with fibroblasts
(some of which may have reached across and indeed
migrated through the 30-lm pore filters) could have
induced cleavage. There is a precedent for proteolysis of
the proteoglycan backbone by members of the MMP or
ADAM family influencing leucocyte recruitment in vivo.46
For example, MMP7-induced shedding of epithelial synd-
ecan-1 was reported to generate a chemotactic gradient
within the peri-vascular space inducing neutrophil migra-
tion into inflamed murine lungs.47 Furthermore, pharma-
cological inhibition of MMP9 attenuated murine
neutrophil and CD4 T-cell migration following hepatic
ischaemic–reperfusion injury.48 Here we found that addi-
tion of galardin to co-cultures (a broad spectrum inhibi-
tor of MMPs and some ADAM family members)
significantly reduced the ability of fibroblasts to inhibit
lymphocyte attachment. In contrast, neither a1-antitrypsin
nor aprotinin (a serine-protease inhibitor) had any effects
on the co-cultures.
We also sought evidence of whether GAGs were neces-
sary for effective lymphocyte adhesion from flow in our
‘undisturbed’ model. Endothelial cells mainly express the
GAG heparan sulphate, along with lower levels of hyaluro-
nan, chrondroitin sulphate and dermatan sulphate.28–31
Here, heparinase treatment of cytokine-treated EC cul-
tured with synovial fibroblast without close contact
reduced lymphocyte adhesion. Hyaluronidase treatment
had no effect. It is notable that in recent studies, we found
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that heparinase treatment did not inhibit neutrophil adhe-
sion to EC treated with TNF-a.31 Hence, disruption of the
glycocalyx mimicked the effect of close contact with fibro-
blasts, inhibiting lymphocyte but not neutrophil binding.
This is consistent with a previous report that the inhibi-
tion of interaction of CXCR3 ligands with heparan sul-
phate suppressed recruitment of CD4 T cells.49
As noted above, the differential effects of fibroblasts on
stable adhesion of lymphocytes and neutrophils could
arise from the cells different requirements for chemokine
presentation. In addition to GAGs, inflammatory chemo-
kines can be presented on the endothelial surface by
DARC (Duffy antigen receptor for chemokines) (reviewed
in ref. 50), which is insensitive to heparinase treatment.51
Previously we reported that CXCL5 (ENA-78) was pre-
sented by DARC to induce neutrophil binding to EC cul-
tured with synovial fibroblasts.17 Overall, it therefore
appears that close contact with fibroblasts may cleave
structures required for chemokine presentation to lym-
phocytes but not to neutrophils.
Our original purpose was to investigate whether fibro-
blasts could actually promote sub-endothelial migration of
leucocytes, especially lymphocytes. Recently, we showed
that migrating lymphocytes, but not neutrophils, tended to
be retained by EC and proposed that a separate signal was
required to induce lymphocyte migration into the stroma.7
We also found that different types of fibroblasts, when co-
cultured with EC without direct contact, could enhance or
inhibit the stable attachment of flowing lymphocytes,
depending on the origin of the fibroblasts.8 This left open
the question of whether fibroblasts could provide signals(s)
to release lymphocytes from the confines of the endothe-
lium or direct their onward migration. Here we used a
modified model with EC and fibroblasts cultured on sepa-
rate 3-lm pore filters one immediately above the other, to
investigate this possibility. Indeed, both dermal and syno-
vial fibroblasts promoted T-cell migration through EC and
its supporting filter. In a previous report, scleroderma fi-
broblasts promoted Jurkat migration through an endothe-
lial cell line, through supply of CCL2 (MCP-1).12 A variety
of chemokines have been identified as playing roles in lym-
phocyte migration into inflamed tissues.52–58 Here, the
most obvious pro-migratory agent shown to be released by
the same fibroblasts in our earlier work, was CXCL12.8,34
However, neutralization of the receptor for this chemokine
did not impair fibroblast-induced migration. Nor did neu-
tralization of IL-6 have any effect, although this agent was
implicated in the capabilities of the fibroblasts to modulate
the earlier lymphocyte adhesion stage in co-cultures.8
The pathophysiological implications of the foregoing
depend on the arrangement of tissue in vivo. In immediate
post-capillary venules where lymphocyte recruitment is
believed to occur in inflammation, the endothelial cells are
closely neighboured by an incomplete covering of pericytes.
In slightly larger vessels a layer of smooth muscle cells
begins to appear. In normal tissue, fibroblasts are likely to
be slightly more remote from the EC, where our results
suggest they would provide regulatory signals in the migra-
tion of neutrophils and especially T cells. However, if tissue
is disrupted and fibroblasts come into direct contact with
EC, then recruitment of lymphocytes (but not neutrophils)
might be suppressed. The effects of pericytes, which are
normally closely juxtaposed to EC on migration, are uncer-
tain, although it has been suggested that they modify the
basement membrane in a manner that facilitates leucocyte
transmigration.59 Several studies have reported the capacity
of pericytes to differentiate into various stromal cell types,
including fibroblasts, implicating them as a potential
source (progenitor) for stromal cells.60–65 It is possible that
they might act like fibroblasts in our model, but distinction
of the functions of pericyte from fibroblasts is made diffi-
cult experimentally by the lack of unique, definitive mark-
ers for either (reviewed in ref. 66). Pericyte-specific
modulation of leucocyte recruitment appears worthy of
further investigation.
Direct contact between fibroblasts and EC may occur
in the contexts of dermal tissue injury (wounding) and
angiogenesis. Several studies have reported the ability of
dermal microvascular endothelial cells to bind and
migrate into dermal fibroblast cultures forming tubule-
like structures, whereas the fibroblasts themselves enhance
and sustain microvessel formation.67–70 Our findings
when fibroblasts and EC were brought into close contact
tally with the observed early recruitment of neutrophils
into wounds without obvious lymphocyte infiltration.71
The same might apply to tissue undergoing neovascular-
ization in chronic inflammatory conditions, or during
disorganized growth of vessels in tumours. Under these
conditions, a restricted or aberrant form of leucocyte
infiltration might prevail until a sufficient remodelling
has occurred. However, if there was a failure to establish
normal architecture, recruitment might continue to differ
from the pattern found in normal resolving inflammatory
responses, e.g. the concept of ‘dissonant orchestration’
describing the inability of leucocytes to infiltrate tumours
in the accepted sequence.72 Stromal architecture also
becomes dramatically disrupted and/or reorganized in
chronically inflamed tissues. A good example of this is
the invasive migration of synovial fibroblasts into the inti-
mal space neighbouring the vascular supply of the rheu-
matoid joint.73 The proximity of stromal cells to the local
microvasculature may change dynamically during tissue
repair, angiogenesis and chronic inflammation, and this
may profoundly modulate leucocyte recruitment.
Overall, the current and previous studies8,16,17 suggest
that stromal fibroblasts can influence both early and late
steps in transendothelial recruitment of leucocytes. For
lymphocytes, it is attractive to propose that fibroblasts
might provide an additional regulatory step in the migra-
tion of T cells, which is not so important for neutrophils.
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Hence, EC exposed to cytokines are able to capture both
types of flowing leucocytes, but can induce efficient
onward migration of neutrophils only. Fibroblasts appear
able to provide the signal for onward migration of lym-
phocytes. An exciting possibility worthy of further investi-
gation is that such signal(s), arising from different
fibroblasts in different tissues, might be sub-set specific.
This would enable the selective migration of discrete pop-
ulations initially recruited by the less-specific adhesive
interaction with the endothelial surface.
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